LivaNova (LIVN) Cash from Investing Activities (2015 - 2026)
LivaNova's (LIVN) quarterly Cash from Investing Activities came in at -$31.9 million in Q2 2026, down 255.9% year-over-year from $20.5 million in Q2 2025, and down 118.91% quarter-over-quarter from -$14.6 million in Q1 2026.
Analysis
LivaNova (LIVN) Cash from Investing Activities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Cash from Investing Activities across 12 years of filings, most recently posting -$31.9 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 255.9% year-over-year to -$31.9 million; the TTM figure through Jun 2026 stood at -$99.8 million (down 104.43% YoY), while the FY2025 annual figure was -$72.9 million, down 51.4% from the prior year.
- Cash from Investing Activities came in at -$31.9 million for Q2 2026 at LivaNova, down from -$14.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$5.5 million in Q1 2022 to a low of -$31.9 million in Q2 2026.
- Average Cash from Investing Activities over 5 years is -$13.7 million, with a median of -$11.2 million recorded in 2022.
- Year-over-year, Cash from Investing Activities surged 58.79% in 2023 and plunged 255.9% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$11.0 million in 2022, then retreated by 10.82% to -$12.1 million in 2023, then rose by 11.78% to -$10.7 million in 2024, then plunged by 182.58% to -$30.3 million in 2025, then declined by 5.48% to -$31.9 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$31.9 million in Q2 2026, -$14.6 million in Q1 2026, and -$30.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | -31.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.92 Mn |
| Mar 31, 2026 | -14.58 Mn |
| Dec 31, 2025 | -30.26 Mn |
| Sep 30, 2025 | -23.06 Mn |
| Jun 30, 2025 | -8.97 Mn |
| Mar 31, 2025 | -10.63 Mn |
| Dec 31, 2024 | -10.71 Mn |
| Sep 30, 2024 | -18.52 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Mar 31, 2024 | -6.36 Mn |
| Dec 31, 2023 | -12.14 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -6.66 Mn |
| Mar 31, 2023 | -11.48 Mn |
| Dec 31, 2022 | -10.95 Mn |
| Sep 30, 2022 | -5.83 Mn |
| Jun 30, 2022 | -16.15 Mn |
| Mar 31, 2022 | -5.48 Mn |
| Dec 31, 2021 | -3.63 Mn |
| Sep 30, 2021 | -6.18 Mn |